We played a major role in revealing the biochemical steps of the RAS-RAF-MAP kinase pathway. We identified one of the major ...
BBOT debuted as a publicly traded company focused on optimized target coverage for patients with tumors driven by RAS and PI3Kα and a synergistic ...
We played a major role in characterising the BRAF gene and its role in cancer, increasing our understanding of malignant melanoma.
Experiments with genetically engineered mice suggest that breaking up the protein partnership could be an effective strategy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback